▲ Peaking
Business
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%
Vertex Pharmaceuticals shares rise as rival Sionna Therapeutics sees its stock collapse following a failed cystic fibrosis drug trial.
Biotech Stocks
1 trends tracked about this subject — the full history, oldest to newest below.